Justina Krotka

发表

Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease

J. Stuchly, M. Trková, E. Froňková, 2022, Leukemia.

Posttreatment positivity of BCR::ABL1 in acute lymphoblastic leukemia: Should we keep track?

J. Zuna, J. Starý, J. Trka, 2023, American journal of hematology.